We are live on ! Find out more
GCM

Glenview Capital Management Portfolio holdings

AUM $3.98B
1-Year Est. Return 20.52%
This Fund
S&P 500
This Quarter Est. Return
-30.58%
1 Year Est. Return
+20.52%
3 Year Est. Return
+68.18%
5 Year Est. Return
+87.14%
10 Year Est. Return
+400.35%
AUM
$3.68B
AUM Growth
-$7.75B
Cap. Flow
-$5.27B
Cap. Flow %
-143.37%
Top 10 Hldgs %
59.91%
Holding
58
New
8
Increased
4
Reduced
26
Closed
14

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$525M
2
HCA icon
HCA Healthcare
HCA
+$408M
3
MCK icon
McKesson
MCK
+$303M
4
DIS icon
Walt Disney
DIS
+$302M
5
HOLX
Hologic
HOLX
+$293M

Sector Composition

Rank Sector Weight
1 Healthcare 68.98%
2 Technology 12.43%
3 Materials 6.14%
4 Communication Services 4.66%
5 Industrials 3.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MOH icon
26
Molina Healthcare
MOH
$10.3B
$38.9M 1.06%
+278,702
New +$37.3M
GPN icon
27
Global Payments
GPN
$22.8B
$36.8M 1%
254,865
-124,217
-33% -$22.7M
ENDP
28
DELISTED
Endo International plc
ENDP
$35.8M 0.97%
9,681,598
-8,788,807
-48% -$44.5M
UHS icon
29
Universal Health Services
UHS
$10.5B
$35.1M 0.95%
354,375
+186,035
+111% +$23.6M
ESI icon
30
Element Solutions
ESI
$9.23B
$33.8M 0.92%
4,047,333
-3,495,068
-46% -$37.2M
CTVA icon
31
Corteva
CTVA
$51.3B
$33.3M 0.91%
1,416,562
-2,083,438
-60% -$57.3M
MSFT icon
32
Microsoft
MSFT
$3.71T
$33M 0.9%
209,477
-1,041
-0.5% -$171K
EBAY icon
33
eBay
EBAY
$49.8B
$25.1M 0.68%
836,096
-1,645,631
-66% -$57.3M
MYGN icon
34
Myriad Genetics
MYGN
$312M
$22M 0.6%
1,539,531
-1,905,264
-55% -$40.2M
NSP icon
35
Insperity
NSP
$2.01B
$16.4M 0.45%
440,733
+205,303
+87% +$14.6M
PACB icon
36
Pacific Biosciences
PACB
$370M
$9.88M 0.27%
3,228,495
-581,154
-15% -$2.38M
ISRG icon
37
Intuitive Surgical
ISRG
$134B
$7.32M 0.2%
+44,337
New +$8.12M
CHRS icon
38
Coherus Oncology
CHRS
$196M
$6.92M 0.19%
+426,738
New +$7.88M
MIK
39
DELISTED
Michaels Stores, Inc
MIK
$4.18M 0.11%
2,582,377
+1,992,118
+337% +$9.43M
ABT icon
40
Abbott
ABT
$187B
$3.69M 0.1%
+46,752
New +$3.9M
MDT icon
41
Medtronic
MDT
$112B
$3.58M 0.1%
+39,671
New +$4.22M
EW icon
42
Edwards Lifesciences
EW
$51.7B
$3.19M 0.09%
+50,718
New +$3.66M
LOW icon
43
Lowe's Companies
LOW
$125B
$2.55M 0.07%
29,630
-1,164,056
-98% -$127M
BA icon
44
Boeing
BA
$185B
-416,863
Closed -$136M
DIS icon
45
Walt Disney
DIS
$181B
-2,088,178
Closed -$302M
DVA icon
46
DaVita
DVA
$11.7B
-1,914,754
Closed -$144M
ELAN icon
47
Elanco Animal Health
ELAN
$11.1B
-2,618,232
Closed -$77.1M
ELV icon
48
Elevance Health
ELV
$85.5B
-751,142
Closed -$227M
FIS icon
49
Fidelity National Information Services
FIS
$22.1B
-397,265
Closed -$55.3M
LYB icon
50
LyondellBasell Industries
LYB
$19.2B
-530,739
Closed -$50.1M

Similar funds

Glenview Capital Management's Q1 2020 Portfolio in Review

As of Q1 2020, Glenview Capital Management held 58 positions worth $3.68B, down 68% from $11.4B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Glenview Capital Management withdrew a net $5.27B in Q1 2020, closing 14 positions and reducing 26 holdings. Its most notable exit was Walt Disney, an estimated $302M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 69% of assets, up from 61% a quarter earlier, followed by Technology and Materials.

Against the trend, Glenview Capital Management opened a new position in Boston Scientific worth $77.9M.

  • Glenview Capital Management's largest Q1 2020 buy was Boston Scientific: 2,387,859 shares worth $77.9M.
  • Glenview Capital Management added most to United Rentals in Q1 2020, an estimated $36.8M increase.
  • Glenview Capital Management's biggest Q1 2020 reduction was Cigna, cutting an estimated $525M.
  • Glenview Capital Management fully exited Walt Disney in Q1 2020, selling an estimated $302M.
  • Glenview Capital Management's ten largest holdings make up 60% of its $3.68B portfolio in Q1 2020.
  • Glenview Capital Management opened 8 new positions and closed 14 in Q1 2020.
  • Glenview Capital Management's portfolio value fell 68% quarter-over-quarter to $3.68B.

Based on Glenview Capital Management's 13F filing for Q1 2020, filed 15 May 2020.